Clinical Trial Update: Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA Patients

View source ↗

Summary

Completed clinical trial assessing ultra-short glucocorticoid therapy in combination with tocilizumab for giant cell arteritis. The update confirms the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis

Drugs mentioned

• Glucocorticoids (ultra-short regimen) (glucocorticoids)
• Tocilizumab (Actemra) (tocilizumab)

Snippet

Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: GCA, TOCILIZUMAB | Status: COMPLETED